A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer
Authors
Keywords
Biliary tract cancer, S-1, Gemcitabine, Refractory
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 71, Issue 5, Pages 1141-1146
Publisher
Springer Nature
Online
2013-03-23
DOI
10.1007/s00280-013-2106-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study
- (2011) Jun Ho Yi et al. EUROPEAN JOURNAL OF CANCER
- Phase II Trial of Erlotinib and Docetaxel in Advanced and Refractory Hepatocellular and Biliary Cancers: Hoosier Oncology Group GI06-101
- (2011) E. G. Chiorean et al. ONCOLOGIST
- Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
- (2010) T Okusaka et al. BRITISH JOURNAL OF CANCER
- Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer
- (2010) Junji Furuse et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness
- (2010) Sung Yong Oh et al. INVESTIGATIONAL NEW DRUGS
- Feasibility study of gemcitabine and cisplatin combination chemotherapy for patients with refractory biliary tract cancer
- (2010) Takashi Sasaki et al. INVESTIGATIONAL NEW DRUGS
- Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine
- (2010) Takashi Sasaki et al. INVESTIGATIONAL NEW DRUGS
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Second-Line Treatment With a Combination of Continuous 5-Fluorouracil, Doxorubicin, and Mitomycin-C (Conti-Fam) in Gemcitabine-Pretreated Pancreatic and Biliary Tract Cancer
- (2009) Suee Lee et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer
- (2009) Junji Furuse et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Capecitabine and Celecoxib as Second-Line Treatment of Advanced Pancreatic and Biliary Tract Cancers
- (2009) Maria S. Pino et al. ONCOLOGY
- Epidemiology of biliary tract cancers: an update
- (2008) G. Randi et al. ANNALS OF ONCOLOGY
- S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study
- (2008) Junji Furuse et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Development History and Concept of an Oral Anticancer Agent S-1 (TS-1(R)): Its Clinical Usefulness and Future Vistas
- (2008) T. Shirasaka JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Systemic Therapy for Biliary Tract Cancers
- (2008) A. F. Hezel et al. ONCOLOGIST
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started